ImageneBio, Inc.
IMA
$5.51
-$0.04-0.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -77.14% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -77.14% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -77.14% | -- | -- | -- |
| SG&A Expenses | 176.95% | 147.00% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 119.39% | 21.61% | -- | -- | -- |
| Operating Income | -165.28% | -30.95% | -- | -- | -- |
| Income Before Tax | -147.22% | -25.01% | -- | -- | -- |
| Income Tax Expenses | -2,715.38% | -2,792.31% | -- | -- | -- |
| Earnings from Continuing Operations | -145.39% | -24.01% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -145.39% | -24.01% | -- | -- | -- |
| EBIT | -165.28% | -30.95% | -- | -- | -- |
| EBITDA | -169.99% | -33.99% | -- | -- | -- |
| EPS Basic | -188.73% | -5,580.47% | -- | -- | -- |
| Normalized Basic EPS | -261.99% | -13,383.77% | -- | -- | -- |
| EPS Diluted | -188.73% | -5,580.47% | -- | -- | -- |
| Normalized Diluted EPS | -261.99% | -13,383.77% | -- | -- | -- |
| Average Basic Shares Outstanding | -92.47% | -96.66% | -- | -- | -- |
| Average Diluted Shares Outstanding | -96.84% | -98.16% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |